Transcriptional gene silencing (TGS) controls the expression of transposable elements and of endogenous genes containing promoter repeats, and it is associated with increased DNA methylation. TGSdeficient mutants impaired in siRNA accumulation and/or chromatin modification (ago4, bru1, cmt3, dcl3, ddm1, drd1, drm2, fas1, fas2, hda6, hog1, met1, mom1, nrpd1a, nrpd1b, nrpd2a, rdr2, suvh2, and suvh4) have been identified, but not all mutations affect the same subset of targets [1-20]. Here, we identify Arabidopsis RPA2, a conserved protein with DNA replication and DNA repair motifs [21], as a novel TGS component that is dispensable for endogenous small RNA accumulation. bru1, cmt3, ddm1, fas1, fas2, hda6, hog1, met1, mom1, and rpa2 mutants are impaired in TGS of dispersed Athila/TSI retrotransposons and of the transgene repeat locus L5, but unlike bru1, cmt3, ddm1, fas1, fas2, hda6, hog1, and met1, the rpa2 and mom1 mutants do not affect the accumulation of 5S-derived siRNAs. Like BRU1, FAS1, FAS2, and MOM1, RPA2 is dispensable for DNA methylation, and rpa2, bru1, fas1, and fas2, but not mom1, mutants are hypersensitive to the DNA damage agent MMS. These results suggest a coordination of the TGS machinery with DNA replication, repair, or recombination machinery at some loci, and they emphasize the diversification of the TGS pathway.
genes in TGS that were not identified in forward genetic screens, suggesting that forward genetic screens were not extensive enough or were too stringent to recover mutants with partial effects. The existence of paralogs with partially redundant functions also could explain why some mutants were not recovered in forward genetic screens. For example, DCL2 and DCL4 produce endogenous RDR2-dependent siRNAs in the absence of DCL3 [23] , probably explaining why dcl3 mutants were not recovered in forward genetic screens and why dcl3 mutants were partially impaired in de novo FWA silencing [4] . In addition, partial functional redundancies likely are the reason for the absence of developmental defects in most mutants (Table 1) . On the other hand, the existence of paralogs with specialized functions could explain why some mutants, such as ago4 or hda6, affect a limited subset of targets [2, 15, 20] . Here, we describe a novel forward, nonstringent genetic screen and the identification of AtRPA2, a new gene controlling TGS and development.
Reactivation of the L5 Locus in Various Mutant Backgrounds
We previously described a transcriptionally silenced and methylated transgene locus, named L5, which consists of three to four T-DNA repeats carrying a pNosnptII selectable marker and a p35S-GUS reporter gene. Fluorometric or histochemical staining assays indicated previously that GUS expression was reactivated to various extents in bru1, ddm1, hda6, hog1, met1, and mom1 mutants [1, 12, 15, 16, 18], but a direct comparison of TGS efficiencies was not possible because the assays were independently performed on different tissues from plants grown in different conditions. To enable a direct comparison of TGS efficiencies in these and other previously unexamined mutants, such as cmt3, drm2, fas1, and fas2, we performed systematic histochemical staining and fluorometric assays on a number of tissues from plants grown under the same conditions (10-day-old whole seedlings; roots, cotyledons, and leaves of 17-day-old seedlings; and leaves, stems, and inflorescences of adult plants). All mutants tested reactivated L5, but the extent of GUS reactivation differed strongly from one mutant to another (Figure 1) . The level of GUS reactivation also differed from one tissue to another, each mutant giving a different pattern of reactivation ( Figures 1B and 1C) . Histochemical staining confirmed that the release of TGS could be tissue specific in several mutants and revealed that this release can also be stochastic within a given tissue (Figures S1, S2, and S3 in the Supplemental Data available with this article online).
Novel Mutants that Release L5 TGS
The systematic analysis described above indicated that the release of TGS can be both partial and tissue specific, which would compromise the identification of mutations with a limited effect on TGS, particularly when using stringent screens such as the reactivation of an antibiotic-resistant gene. To identify novel TGS mutants, we mutagenized L5 seeds by fast-neutron mutagenesis and screened 17-day-old mutants for novel patterns of GUS reactivation by histochemical staining. Two mutants isolated during this screen, named 300-8 and 450-12, had similar GUS expression patterns ( DNA break repair that is associated with breast cancer susceptibility [21] . For determining whether At2g24490/ RPA2 plays a role in DNA repair, wild-type L5 plants and 450-12/rpa2-2 mutants were grown on medium supplemented with methyl methane sulfonate (MMS), a chemical that alkylates DNA and is considered to mimic double-strand-DNA break damage [18] . Like bru1, fas1,  and fas2, but not ddm1, met1, and mom1 [18] , the rpa2 mutant was hypersensitive to MMS (Figure 2D ), suggesting that AtRPA2 has a functional DNA repair domain and acts with BRU1, FAS1, and FAS2 in both the TGS and DNA repair pathways. (ago4, cmt3, dcl3, ddm1, drd1, drm2, hda6, hog1,  met1, nrpd1a, nrpd1b, nrpd2a, rdr2, suvh2, and suvh4)  [2-17, 19, 20] , whereas other mutations (bru1, fas1, fas2, and mom1) have been reported to have no effect [1, 18] . For determining whether rpa2 mutants are impaired in DNA methylation at CG, CNG, and CNN sites, DNA was digested with HpaII, MspI, or HaeIII and hybridized with probes corresponding to either the 35S promoter of the transgene carried at the L5 locus, the 5S ribosomal DNA, the 180 bp contromeric repeat, or the Athila/TSI retrotransposon ( Figure 3A) . These repeated sequences, which are naturally methylated in wild-type plants, remained methylated in the rpa2 mutants, suggesting that RPA2 likely is dispensable for DNA methylation at these loci. However, we cannot exclude that RPA2 may have subtle effects or, like AGO4 or HDA6, could be required for DNA methylation at other untested loci [2, 20] . Mutations that are in chromatin-related genes (like  BRU1, CMT3, DDM1, FAS1, FAS2, HDA6, HOG1, MET1 , MOM1, SUVH2, and SUVH4) and affect repeat-transgene-induced TGS also affect Athila/TSI retrotransposon silencing to various extents [ 1, 6, 10, 13, 15, 17,  18 ]. In contrast, mutations that are in chromatin-related genes (like DRD1, NRPD1b, and NRPD2a) and affect siRNA-directed TGS of single transgene copy do not affect Athila/TSI silencing [9] , suggesting that the maintenance of TGS at Athila/TSI loci and repeat-transgene loci requires the same machinery. For determining whether rpa2 mutants are impaired in Athila/TSI silencing, high molecular weight RNA was extracted and hybridized with a TSI probe. Unlike in wild-type control plants, TSI RNA was detected in rpa2-2 and rpa2-3 mutants. However, the accumulation of TSI RNA was lower than in ddm1, met1, and mom1, indicating that RPA2 has a modest effect on Athila/TSI silencing ( Figure 3B ). The intensity of Athila/TSI reactivation in the different mutants ( [17] and Figure 3B ) correlated with that of the p35S-GUS transgene carried by the L5 locus (Figure 1) , reinforcing the hypothesis that the maintenance of TGS at L5 and Athila/TSI loci requires the same machinery.
AtRPA2 Likely Is Dispensable for DNA Methylation Some mutations that release TGS affect DNA methylation to various extents and with various specificities

Mutations in the AtRPA2 Gene Reactivate Athila/TSI Retrotransposons
AtRPA2 Likely Is Dispensable for the Accumulation of Small RNAs
The TGS-deficient mutants ago4, cmt3, dcl3, ddm1, drm2, hda6, met1, nrpd1a, nrpd2a, and rdr2 are impaired in the accumulation of some endogenous siRNAs, although to various extents [5, 9, 11, 14, 19]. For example, the 5S-repeat-derived siRNA1003 is not detectable in ago4, dcl3, drm2, nrpd1a, nrpd2a, and rdr2, whereas it accumulates in cmt3, ddm1, and met1 [5, 9, 14, 19, 22]. However, ddm1 and met1 overaccumulate siRNA1003 [14] , presumably because DDM1 and MET1 are required for siRNA-directed transcriptional repression of 5S repeats. Thus, derepression of 5S-repeat transcription, despite the presence of 5S siRNAs, results in the amplification of siRNA accumulation [14] . To determine the impact of rpa2 and other uncharacterized mutants, we monitored siRNA1003 accumulation in these mutants ( Figure 3C ). As previously reported, the level of siRNA1003 was decreased in ago4, dcl3, drm2, nrpd1a, and rdr2 [5, 19, 20] and increased in ddm1 and met1 [14] . siRNA1003 accumulation also was increased to various extents in bru1, cmt3, fas1, fas2, hda6, hog1, and suvh4 ( Figure 3C ). Therefore, it is possible that BRU1, CMT3, DDM1, FAS1, FAS2, HDA6, HOG1, MET1, and SUHV4 control the transcription of 5S repeats. In contrast, siRNA1003 accumulated to similar levels in wild-type plants and mom1 and rpa2 mutants, suggesting that MOM1 and RPA2 are dispensable for the regulation of 5S-repeat transcription.
We also monitored the accumulation of other classes of endogenous small RNAs: microRNAs miR159, miR173, and miR390; trans-acting siRNAs deriving from TAS2 and TAS3 loci; and RDR2-dependent siRNA02. All of the endogenous small RNAs tested accumulated to wild-type levels in rpa2 mutants (Figures 3C and 3D) , indicating that RPA2 is not required for the accumulation of these small RNAs. Unlike ddm1 and met1, which partially impair posttranscriptional gene silencing (PTGS) of the p35S-GUS transgene carried at the L1 locus [12] , rpa2 mutants were not impaired in L1 PTGS (data not shown), indicating that RPA2 is dispensable for another siRNA-mediated pathway.
Conclusions
In plants, various TGS pathways exist that require the action of various combinations of the following components: AGO4, BRU1, CMT3, DCL3, DDM1, DRD1, DRM2,  FAS1, FAS2, HDA6/SIL1, HOG1, MET1 data). Nevertheless, it is possible that low siRNA amounts that remain associated to the L5 locus and act only in cis could be produced through another pathway, given the redundancy among the four Arabidopsis DCL proteins [23] .
Like BRU1, FAS1, FAS2, and MOM1, the newly identified TGS component RPA2 is required for maintenance of TGS at Athila/TSI retrotransposons and L5 transgene repeats but is not required for DNA methylation of the tested loci. Like BRU1, FAS1, and FAS2, but not MOM1, RPA2 acts in the DNA repair pathway (Table  1) . Unlike mutations in BRU1, FAS1, and FAS2, which lead to increased 5S-siRNA accumulation, mutations in RPA2 and MOM1 do not affect 5S-siRNA accumulation, emphasizing the diversification of TGS pathways. We anticipate that additional genetic screens based on the reactivation of different targets will identify novel components of the TGS machinery. 
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